FLT3 and acute myeloid leukemia: In our study, we only showed FLT3-ITD mutations could predict unfavorable outcome of pediatric CN-AML patients (P = 0.003), but we failed to find the relationship between NPM1 and CEBPA mutation and patients’ prognosis.